A2A Pharmaceuticals, Inc. 4
4 · Biomea Fusion, Inc. · Filed Apr 6, 2023
Insider Transaction Report
Form 4
A2A Pharmaceuticals, Inc.
10% Owner
Transactions
- Sale
Common Stock
2023-03-31$31.25/sh+200,000$6,250,000→ 4,100,000 total
Footnotes (1)
- [F1]A total of 200,000 shares were sold at an average price of 31.25 in multiple transactions ranging in price from 30.87 to 31.64